S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
pixel
S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
pixel
S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
pixel
S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
pixel
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Tandem Diabetes CareHaemoneticsNevroGlobus MedicalInspire Medical Systems
SymbolNASDAQ:TNDMNYSE:HAENYSE:NVRONYSE:GMEDNYSE:INSP
Price Information
Current Price$100.48$123.17$176.32$64.44$214.93
52 Week RangeBuyBuyBuyBuyBuy
MarketRank™
Overall Score1.41.41.21.41.4
Analysis Score2.31.42.41.42.4
Community Score2.52.23.02.82.4
Dividend Score0.00.00.00.00.0
Ownership Score1.71.70.00.81.7
Earnings & Valuation Score0.61.90.61.90.6
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$114.57$132.40$178.92$62.79$152.00
% Upside from Price Target14.02% upside7.49% upside1.47% upside-2.57% downside-29.28% downside
Trade Information
Market Cap$6.12 billion$6.25 billion$6.07 billion$6.36 billion$5.79 billion
Beta0.310.561.021.021.71
Average Volume740,340400,416598,134470,320248,489
Sales & Book Value
Annual Revenue$362.30 million$988.48 million$390.26 million$785.37 million$82.05 million
Price / Sales16.896.3315.568.1070.56
CashflowN/A$5.45 per shareN/A$2.19 per shareN/A
Price / CashN/A22.59N/A29.41N/A
Book Value$3.30 per share$11.67 per share$6.98 per share$14.05 per share$5.81 per share
Price / Book30.4510.5525.264.5936.99
Profitability
Net Income$-24,750,000.00$76.53 million$-103,690,000.00$155.21 million$-33,240,000.00
EPS($0.22)$3.31($3.37)$1.68($1.40)
Trailing P/E RatioN/A59.50N/A70.04N/A
Forward P/E RatioN/A35.09N/A31.59N/A
P/E GrowthN/A5.17N/A2.89N/A
Net Margins-11.10%11.76%-24.46%12.36%-61.07%
Return on Equity (ROE)-10.98%22.85%-30.25%9.85%-32.23%
Return on Assets (ROA)-5.59%10.40%-14.57%9.04%-26.42%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.61%0.44%0.37%N/A0.11%
Current Ratio5.61%2.25%3.10%8.12%14.67%
Quick Ratio4.94%1.34%2.75%5.80%14.18%
Ownership Information
Institutional Ownership Percentage88.60%96.22%N/A64.35%96.30%
Insider Ownership Percentage6.00%1.63%7.60%25.63%6.60%
Miscellaneous
Employees1,0433,0048532,000239
Shares Outstanding60.91 million50.78 million34.43 million98.68 million26.94 million
Next Earnings Date2/24/2021 (Confirmed)2/2/2021 (Confirmed)2/24/2021 (Confirmed)2/18/2021 (Estimated)2/23/2021 (Confirmed)
OptionableOptionableOptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.